IN190831B - - Google Patents
Info
- Publication number
- IN190831B IN190831B IN453DE1999A IN190831B IN 190831 B IN190831 B IN 190831B IN 453DE1999 A IN453DE1999 A IN 453DE1999A IN 190831 B IN190831 B IN 190831B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN453DE1999 IN190831B (no) | 1999-03-19 | 1999-03-19 | |
| US09/366,986 US6346530B1 (en) | 1999-03-19 | 1999-08-04 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| EP00909562A EP1165051B1 (en) | 1999-03-19 | 2000-03-17 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| AT00909562T ATE244560T1 (de) | 1999-03-19 | 2000-03-17 | Verfahren zur herstellung einer bioverfügbaren oralen darreichungsform von cefuroxim-axetil |
| ES00909562T ES2202069T3 (es) | 1999-03-19 | 2000-03-17 | Procedimiento para la preparacion de una forma de dosificacion oral biodisponible de axetil cefuroxima. |
| BR0009177-4A BR0009177A (pt) | 1999-03-19 | 2000-03-17 | Processo para preparação de uma forma de dosagem oral biodisponìvel de axetil cefuroxima |
| AU31843/00A AU3184300A (en) | 1999-03-19 | 2000-03-17 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| PCT/IB2000/000292 WO2000056286A1 (en) | 1999-03-19 | 2000-03-17 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| CA002366617A CA2366617A1 (en) | 1999-03-19 | 2000-03-17 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil |
| PT00909562T PT1165051E (pt) | 1999-03-19 | 2000-03-17 | Processo para a preparacao de uma forma de dosagem oral biodisponivel de cefuroxima axetil |
| US09/642,402 US6323193B1 (en) | 1999-03-19 | 2000-08-21 | Bioavailable oral dosage form of cefuroxime axetil |
| ZA200107718A ZA200107718B (en) | 1999-03-19 | 2001-09-18 | Process for the preparation of a bioavailable oral dosage form of cefuroxime axetil. |
| HK02104843.9A HK1043540B (zh) | 1999-03-19 | 2002-06-28 | 製備生物可利用的頭孢呋肟酯口服劑型的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN453DE1999 IN190831B (no) | 1999-03-19 | 1999-03-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN190831B true IN190831B (no) | 2003-08-23 |
Family
ID=11089857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN453DE1999 IN190831B (no) | 1999-03-19 | 1999-03-19 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US6346530B1 (no) |
| IN (1) | IN190831B (no) |
| ZA (1) | ZA200107718B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100448879C (zh) * | 2004-07-22 | 2009-01-07 | 北京化工大学 | 一种无定型头孢呋辛酯的制备方法 |
| DE102005019458A1 (de) * | 2005-04-25 | 2006-10-26 | Grünenthal GmbH | Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil |
| WO2007063552A1 (en) | 2005-12-02 | 2007-06-07 | Lupin Limited | Stable taste masked formulations of cephalosporins |
| CN102697747A (zh) * | 2012-06-13 | 2012-10-03 | 广州南新制药有限公司 | 一种头孢呋辛酯的分散片 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1094545A (en) | 1976-02-16 | 1981-01-27 | Michael Gregson | Cephalosporin antibiotics |
| NL193682C (nl) * | 1987-05-14 | 2000-07-04 | Glaxo Group Ltd | Beklede cefuroximaxetilsamenstelling. |
| US5063224A (en) * | 1990-07-09 | 1991-11-05 | Eli Lilly And Company | R-cefuroxime axetil |
| NZ299077A (en) * | 1996-07-26 | 1998-06-26 | Apotex Inc | Preparation of amorphous cefuroxime axetil (a cephalosporin derivative) by dissolving crystalline cefuroxim axetil in a highly polar solvent, typically dmso and/or dmf |
| IN186539B (no) * | 1997-09-29 | 2001-09-29 | Ranbaxy Lab Ltd |
-
1999
- 1999-03-19 IN IN453DE1999 patent/IN190831B/en unknown
- 1999-08-04 US US09/366,986 patent/US6346530B1/en not_active Expired - Fee Related
-
2001
- 2001-09-18 ZA ZA200107718A patent/ZA200107718B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200107718B (en) | 2002-05-09 |
| US6346530B1 (en) | 2002-02-12 |